Home >
NEWS
"Business Trip to Japan's Pharmaceutical Raw Material Exhibition in 2023"
"2023 is a worth looking forward to for development year. During our company's visit to Japan, we attended the 2023 CPHI exhibition and met many new partners. We also had a meeting with a large domestic pharmaceutical factory to exchange views on..
2023-04-24
"China Pharmaceutical Internal Circulation Big Platform - Qingdao Exhibition"
On April 12th, the 88th China Pharmaceutical Raw Materials/Intermediates/Packaging/Equipment Fair and the 26th China International Pharmaceutical (Industry) Exhibition and Technical Exchange (hereinafter referred to as the API Exhibition) opened at the China R..
2023-04-17
ASIA PHARMA EXPO DHAKA BANGLADESH
After three years of restricted travel due to the pandemic, we are finally able to meet our clients in person again. Our first destination this time was an exhibition in Bangladesh! The booth was filled with people from all over the world, and the lively atmos..
2023-03-24
Molnupiravir FDA Approval Status
Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog in development for the treatment of COVID-19.1.Molnupiravir works as an antiviral agent by inhibiting the replication of the SARS-CoV-2 virus, th..
2021-10-25
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: Room2012, Tower A of Shangmei International Building, 1355# Liuxian Avenue, Nanshan Dist., Shenzhen, China 518055 Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com
Address: Room2012, Tower A of Shangmei International Building, 1355# Liuxian Avenue, Nanshan Dist., Shenzhen, China 518055 Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com